The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations

Journal of Investigative Dermatology

Volumn 131, Issue 2, 2011, Pages 542-545

  Zalaudek, Iris ^a   Guelly, Christian ^a   Pellacani, Giovanni ^b   Hofmann Wellenhof, Rainer ^c   Trajanoski, Slave ^a   Kittler, Harald ^c   Scope, Alon ^d   Marghoob, Ashfaq A ^e   Longo, Caterina ^b   Leinweber, Bernd ^a   Ferrara, Gerardo ^f   Saida, Toshiaki ^g   Grichnik, James M ^h   Argenziano, Giuseppe ⁱ   Becker, Jürgen C ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Universitatsklinik fur Dermatologie   (Austria)

^d SHEBA MEDICAL CENTER   (Israel)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f G RUMMO HOSPITAL   (Italy)

^g SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

ADULT; AGE; CLINICAL ARTICLE; EPILUMINESCENCE MICROSCOPY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LETTER; MALE; MUTATION RATE; NEVUS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 78651396841     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.332     Document Type: Letter

References (14)

1. Gray-Schopfer VC, Cheong SC, Chong H et al. (2006) Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 95:496-505
2. Houben R, Ortmann S, Drasche A et al. (2009) Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation. J Invest Dermatol 129:406-14
3. Huse SM, Huber JA, Morrison HG et al. (2007) Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol 8:R143
4. Kittler H, Seltenheim M, Dawid M et al. (2000) Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol 136:316-20
5. Lin J, Takata M, Murata H et al. (2009) Polyclonality of BRAF mutations in acquired melanocytic nevi. J Natl Cancer Inst 101:1423-7
6. Loewe R, Kittler H, Fischer G et al. (2004) BRAF kinase gene V599E mutation in growing melanocytic lesions. J Invest Dermatol 123:733-6
7. Michaloglou C, Vredeveld LC, Soengas MS et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720-4
8. Scurr LL, Pupo GM, Becker TM et al. (2010) IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell 141:717-27
9. Scope A, Marghoob AA, Dusza SW et al. (2008) Dermoscopic patterns of naevi in fifth grade children of the Framingham school system. Br J Dermatol 158:1041-9
10. Takata M, Murata H, Saida T (2010) Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma. Pigment Cell Melanoma Res 23:64-71
11. Tan YH, Liu Y, Eu KW et al. (2008) Detection of BRAF V600E mutation by pyrosequencing. Pathology 40:295-8
12. Thomas NE (2006) BRAF somatic mutations in malignant melanoma and melanocytic naevi. Melanoma Res 16:97-103
13. Wu J, Rosenbaum E, Begum S et al. (2007) Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumori-genesis. Am J Dermatopathol 29:534-7
14. Zalaudek I, Grinschgl S, Argenziano G et al. (2006) Age-related prevalence of dermo-scopy patterns in acquired melanocytic naevi. Br J Dermatol 154:299-304